Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis
Dana-Farber/Harvard Cancer Center · Novartis (United States)
Abstract
In a longitudinal clinical study to compare two groups, the primary end point is often the time to a specific event (eg, disease progression, death). The hazard ratio estimate is routinely used to empirically quantify the between-group difference under the assumption that the ratio of the two hazard functions is approximately constant over time. When this assumption is plausible, such a ratio estimate may capture the relative difference between two survival curves. However, the clinical meaning of such a ratio estimate is difficult, if not impossible, to interpret when the underlying proportional hazards assumption is violated (ie, the hazard ratio is not constant over time). Although this issue has been…
Citation impact
- FWCI
- 29.22
- Percentile
- 100%
- References
- 28
Authors
16Topics & keywords
- Hazard ratio
- Hazard
- Statistics
- Medicine
- Estimator
- Event (particle physics)
- Econometrics
- Proportional hazards model
- Good health and well-being